カテゴリー： QYResearch, 世界

体部白癬用薬の世界市場：規模・現状・予測

◆英語タイトル：Global Tinea Corporis Drugs Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X19035
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、体部白癬用薬の世界市場について調査・分析し、体部白癬用薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗真菌剤、ステロイド、抗感染性組み合わせ）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の体部白癬用薬市場動向
・主要企業別マーケットシェア
・体部白癬用薬の種類別市場規模2014-2019
（抗真菌剤、ステロイド、抗感染性組み合わせ）
・体部白癬用薬の用途別市場規模2014-2019
（病院薬局、小売薬局、オンライン薬局）
・体部白癬用薬の北米市場：主要企業・種類別/用途別市場規模
・体部白癬用薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・体部白癬用薬の中国市場：主要企業・種類別/用途別市場規模
・体部白癬用薬の日本国内市場：主要企業・種類別/用途別市場規模
・体部白癬用薬の東南アジア市場：主要企業・種類別/用途別市場規模
・体部白癬用薬のインド市場：主要企業・種類別/用途別市場規模
・体部白癬用薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Sun Pharmaceutical、Teva、Glenmark、Aurobindo、AvKare、Novartis、Sebela、Bayer）
・体部白癬用薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tinea Corporis Drugs development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.

The key players covered in this study
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer

Market segment by Type, the product can be split into
Antifungals
Steroids
Anti-Infective Combinations

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tinea Corporis Drugs development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tinea Corporis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tinea Corporis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Antifungals
1.4.3 Steroids
1.4.4 Anti-Infective Combinations
1.5 Market by Application
1.5.1 Global Tinea Corporis Drugs Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tinea Corporis Drugs Market Size
2.2 Tinea Corporis Drugs Growth Trends by Regions
2.2.1 Tinea Corporis Drugs Market Size by Regions (2019-2025)
2.2.2 Tinea Corporis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Tinea Corporis Drugs Market Size by by Players
3.1.1 Global Tinea Corporis Drugs Revenue by by Players (2014-2019)
3.1.2 Global Tinea Corporis Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Tinea Corporis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tinea Corporis Drugs Key Players Head office and Area Served
3.3 Key Players Tinea Corporis Drugs Product/Solution/Service
3.4 Date of Enter into Tinea Corporis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tinea Corporis Drugs Market Size by Type (2014-2019)
4.2 Global Tinea Corporis Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Tinea Corporis Drugs Market Size (2014-2019)
5.2 Tinea Corporis Drugs Key Players in North America
5.3 North America Tinea Corporis Drugs Market Size by Type
5.4 North America Tinea Corporis Drugs Market Size by Application

6 Europe
6.1 Europe Tinea Corporis Drugs Market Size (2014-2019)
6.2 Tinea Corporis Drugs Key Players in Europe
6.3 Europe Tinea Corporis Drugs Market Size by Type
6.4 Europe Tinea Corporis Drugs Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Tinea Corporis Drugs Market Size (2014-2019)
7.2 Tinea Corporis Drugs Key Players in Asia-Pacific
7.3 Asia-Pacific Tinea Corporis Drugs Market Size by Type
7.4 Asia-Pacific Tinea Corporis Drugs Market Size by Application

8 Southeast Asia
8.1 Southeast Asia Tinea Corporis Drugs Market Size (2014-2019)
8.2 Tinea Corporis Drugs Key Players in Southeast Asia
8.3 Southeast Asia Tinea Corporis Drugs Market Size by Type
8.4 Southeast Asia Tinea Corporis Drugs Market Size by Application

9 India
9.1 India Tinea Corporis Drugs Market Size (2014-2019)
9.2 Tinea Corporis Drugs Key Players in India
9.3 India Tinea Corporis Drugs Market Size by Type
9.4 India Tinea Corporis Drugs Market Size by Application

10 Central & South America
10.1 Central & South America Tinea Corporis Drugs Market Size (2014-2019)
10.2 Tinea Corporis Drugs Key Players in Central & South America
10.3 Central & South America Tinea Corporis Drugs Market Size by Type
10.4 Central & South America Tinea Corporis Drugs Market Size by Application

11 International Players Profiles
11.1 Sun Pharmaceutical
11.1.1 Sun Pharmaceutical Company Details
11.1.2 Company Description and Business Overview
11.1.3 Tinea Corporis Drugs Introduction
11.1.4 Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2014-2019))
11.1.5 Sun Pharmaceutical Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Description and Business Overview
11.2.3 Tinea Corporis Drugs Introduction
11.2.4 Teva Revenue in Tinea Corporis Drugs Business (2014-2019)
11.2.5 Teva Recent Development
11.3 Glenmark
11.3.1 Glenmark Company Details
11.3.2 Company Description and Business Overview
11.3.3 Tinea Corporis Drugs Introduction
11.3.4 Glenmark Revenue in Tinea Corporis Drugs Business (2014-2019)
11.3.5 Glenmark Recent Development
11.4 Aurobindo
11.4.1 Aurobindo Company Details
11.4.2 Company Description and Business Overview
11.4.3 Tinea Corporis Drugs Introduction
11.4.4 Aurobindo Revenue in Tinea Corporis Drugs Business (2014-2019)
11.4.5 Aurobindo Recent Development
11.5 AvKare
11.5.1 AvKare Company Details
11.5.2 Company Description and Business Overview
11.5.3 Tinea Corporis Drugs Introduction
11.5.4 AvKare Revenue in Tinea Corporis Drugs Business (2014-2019)
11.5.5 AvKare Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Tinea Corporis Drugs Introduction
11.6.4 Novartis Revenue in Tinea Corporis Drugs Business (2014-2019)
11.6.5 Novartis Recent Development
11.7 Sebela
11.7.1 Sebela Company Details
11.7.2 Company Description and Business Overview
11.7.3 Tinea Corporis Drugs Introduction
11.7.4 Sebela Revenue in Tinea Corporis Drugs Business (2014-2019)
11.7.5 Sebela Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Company Description and Business Overview
11.8.3 Tinea Corporis Drugs Introduction
11.8.4 Bayer Revenue in Tinea Corporis Drugs Business (2014-2019)
11.8.5 Bayer Recent Development

12 Market Forecast 2019-2025
12.1 Market Size Forecast by Product (2019-2025)
12.2 Market Size Forecast by Application (2019-2025)
12.3 Market Size Forecast by Regions
12.4 North America
12.5 Europe
12.6 Asia-Pacific
12.8 Southeast Asia
12.9 India
12.10 Central & South America

13 Analyst’s Viewpoints/Conclusions

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
14.3 Author Details

List of Tables and Figures

Table Tinea Corporis Drugs Key Market Segments
Table Key Players Tinea Corporis Drugs Covered
Table Global Tinea Corporis Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antifungals Figures
Table Key Players of Antifungals
Figuer Steroids Figures
Table Key Players of Steroids
Figuer Anti-Infective Combinations Figures
Table Key Players of Anti-Infective Combinations
Table Global Tinea Corporis Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Tinea Corporis Drugs Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Tinea Corporis Drugs Report Years Considered
Figure Global Tinea Corporis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tinea Corporis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tinea Corporis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tinea Corporis Drugs Market Share by Regions 2014-2019
Figure Global Tinea Corporis Drugs Market Share by Regions 2014-2019
Figure Global Tinea Corporis Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Tinea Corporis Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Tinea Corporis Drugs Market Share by by Players (2014-2019)
Figure Global Tinea Corporis Drugs Market Share by by Players in 2018
Table Global Tinea Corporis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tinea Corporis Drugs Product/Solution/Service
Table Date of Enter into Tinea Corporis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tinea Corporis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Tinea Corporis Drugs Market Size Share by Type (2014-2019)
Figure Global Tinea Corporis Drugs Market Size Market Share by Type (2014-2019)
Table Global Tinea Corporis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Tinea Corporis Drugs Market Size Share by Application (2014-2019)
Figure Global Tinea Corporis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Tinea Corporis Drugs Revenue Market Share by Application in 2018
Figure North America Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table North America Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Tinea Corporis Drugs Market Share by Type 2014-2019
Table North America Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Tinea Corporis Drugs Market Share by Application 2014-2019
Figure Europe Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table Europe Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Tinea Corporis Drugs Market Share by Type 2014-2019
Table Europe Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Tinea Corporis Drugs Market Share by Application 2014-2019
Figure Asia-Pacific Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table Asia-Pacific Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Tinea Corporis Drugs Market Share by Type 2014-2019
Table Asia-Pacific Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Tinea Corporis Drugs Market Share by Application 2014-2019
Figure Southeast Asia Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table Southeast Asia Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Tinea Corporis Drugs Market Share by Type 2014-2019
Table Southeast Asia Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Tinea Corporis Drugs Market Share by Application 2014-2019
Figure India Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table India Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table India Tinea Corporis Drugs Market Share by Type 2014-2019
Table India Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table India Tinea Corporis Drugs Market Share by Application 2014-2019
Figure Central & South America Tinea Corporis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tinea Corporis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tinea Corporis Drugs Market Share (2018-2019)
Table Central & South America Tinea Corporis Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Tinea Corporis Drugs Market Share by Type 2014-2019
Table Central & South America Tinea Corporis Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Tinea Corporis Drugs Market Share by Application 2014-2019
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Teva Company Details
Table Teva Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Teva Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Glenmark Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Glenmark Recent Development
Table Aurobindo Company Details
Table Aurobindo Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Aurobindo Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Aurobindo Recent Development
Table AvKare Company Details
Table AvKare Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure AvKare Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table AvKare Recent Development
Table Novartis Company Details
Table Novartis Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Novartis Recent Development
Table Sebela Company Details
Table Sebela Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Sebela Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Sebela Recent Development
Table Bayer Company Details
Table Bayer Revenue in Tinea Corporis Drugs Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Tinea Corporis Drugs Business (2014-2019)
Table Bayer Recent Development
Table Global Tinea Corporis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Tinea Corporis Drugs Market Size Share by Regions (2019-2025)
Figure Global Tinea Corporis Drugs Market Size Share by Regions in 2025
Figure North America Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tinea Corporis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Tinea Corporis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Tinea Corporis Drugs Market Size by Product (2019-2025)
Figure Global Tinea Corporis Drugs Market Size by Product in 2025
Table Global Tinea Corporis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Tinea Corporis Drugs Market Size by Application (2019-2025)
Figure Global Tinea Corporis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Sun Pharmaceutical、Teva、Glenmark、Aurobindo、AvKare、Novartis、Sebela、Bayer

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 体部白癬用薬の世界市場：規模・現状・予測(Global Tinea Corporis Drugs Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp